Nu Skin Enterprises Stock Alpha and Beta Analysis

NUS Stock  USD 7.55  0.33  4.57%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Nu Skin Enterprises. It also helps investors analyze the systematic and unsystematic risks associated with investing in Nu Skin over a specified time horizon. Remember, high Nu Skin's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Nu Skin's market risk premium analysis include:
Beta
0.35
Alpha
(0.41)
Risk
3.34
Sharpe Ratio
(0.07)
Expected Return
(0.22)
Please note that although Nu Skin alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Nu Skin did 0.41  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Nu Skin Enterprises stock's relative risk over its benchmark. Nu Skin Enterprises has a beta of 0.35  . As returns on the market increase, Nu Skin's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nu Skin is expected to be smaller as well. At this time, Nu Skin's Book Value Per Share is comparatively stable compared to the past year. Tangible Book Value Per Share is likely to gain to 10.26 in 2024, whereas Price Book Value Ratio is likely to drop 1.12 in 2024.

Nu Skin Quarterly Cash And Equivalents

233.31 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Nu Skin Backtesting, Nu Skin Valuation, Nu Skin Correlation, Nu Skin Hype Analysis, Nu Skin Volatility, Nu Skin History and analyze Nu Skin Performance.

Nu Skin Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Nu Skin market risk premium is the additional return an investor will receive from holding Nu Skin long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Nu Skin. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Nu Skin's performance over market.
α-0.41   β0.35

Nu Skin expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Nu Skin's Buy-and-hold return. Our buy-and-hold chart shows how Nu Skin performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Nu Skin Market Price Analysis

Market price analysis indicators help investors to evaluate how Nu Skin stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nu Skin shares will generate the highest return on investment. By understating and applying Nu Skin stock market price indicators, traders can identify Nu Skin position entry and exit signals to maximize returns.

Nu Skin Return and Market Media

The median price of Nu Skin for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 7.11 with a coefficient of variation of 13.85. The daily time series for the period is distributed with a sample standard deviation of 0.99, arithmetic mean of 7.17, and mean deviation of 0.75. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
 
Nu Skin dividend paid on 11th of September 2024
09/11/2024
1
New Data Gen Z Most Likely to Trust Influencer Gift Recommendations, but Need the Most Touchpoints for a Sell
10/03/2024
2
STATE STREET CORPs Strategic Reduction in Nu Skin Enterprises Inc Holdings
10/18/2024
3
Acquisition by Emma Battle of 4232 shares of Nu Skin subject to Rule 16b-3
10/30/2024
4
E.l.f. Beauty Q2 Earnings and Revenues Beat Estimates
11/06/2024
5
Nu Skin Enterprises Reports Third Quarter Results
11/07/2024
6
Nu Skin Enterprises Inc Q3 2024 Earnings Call Highlights Navigating Challenges with ...
11/08/2024
7
Acquisition by Ryan Napierski of 21513 shares of Nu Skin at 30.63 subject to Rule 16b-3
11/11/2024
8
Does Nu Skin Enterprises Have A Healthy Balance Sheet
11/12/2024

About Nu Skin Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NUS or other stocks. Alpha measures the amount that position in Nu Skin Enterprises has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 (projected)
Dividend Yield0.03650.08040.0844
Price To Sales Ratio0.950.490.47

Nu Skin Upcoming Company Events

As portrayed in its financial statements, the presentation of Nu Skin's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nu Skin's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Nu Skin's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Nu Skin. Please utilize our Beneish M Score to check the likelihood of Nu Skin's management manipulating its earnings.
14th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Nu Skin

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.